Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02117024
Title A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Heat Biologics

lung non-small cell carcinoma


Cyclophosphamide + HS-110

Pemetrexed Disodium






Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Highlands Oncology Group Rogers Arkansas 72758 United States Details
University of California San Diego La Jolla California 92093 United States Details
University of California at Los Angeles Los Angeles California 90029 United States Details
University of California Davis Sacramento California 95817 United States Details
Georgia Regents University Augusta Georgia 30912 United States Details
University of Maryland Greenebaum Cancer Center Baltimore Maryland 21201 United States Details
University of Massachusetts Worcester Massachusetts 01655 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
SUNY Syracuse Syracuse New York 13210 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
Providence Portland Medical Center- Providence Lung Cancer Clinic Portland Oregon 97213 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Texas Oncology PA Texas Cancer Center Abilene Texas 79606 United States Details
Mary Crowley Cancer Center Dallas Texas 75201 United States Details
Cancer Care Northwest Spokane Washington 99216 United States Details
Aurora Research Institute Green Bay Wisconsin 54311 United States Details
*Shaded cells indicate that there was no data available from for the field